Chronic Diseases Are Killing More in Poorer Countries

Chronic diseases like cancer and heart disease are rising fast in low- and middle-income countries, striking far younger populations than in rich countries and causing much...

‘Superbugs’ Kill India’s Babies and Pose an Overseas Threat

AMRAVATI, India — A deadly epidemic that could have global implications is quietly sweeping India, and among its many victims are tens of thousands of newborns dying ...

2 dose HPV vaccines recommended by WHO to protect against cervical cancer

Girls can be vaccinated with two doses of HPV vaccine to protect against cervical cancer instead of three, the World Health Organization now advises, based in part on Canad...

How close are we to finding a cure for HIV?

World Aids Day takes place on 1 December, with the Human Immunodeficiency Virus (HIV) continuing to be a major global public health issue. So far, Acquired Immunodeficiency...

Maternal pertussis vaccine during pregnancy protected infants

“Our results provide good evidence for pregnant women and health professionals to make informed decisions about the effectiveness of maternal vaccination in protectin...

War on the ‘Malaria mayhem’ in Mumbai reduces infection by 80%

How did the local government, a thinktank, tiffin box delivery men and a superhero reduce infections so dramatically?

Indians take to the streets in celebration as ...

Greed of Drug Industry Cited by World Health as Reason for Lack of Ebola Vaccine

“A profit-driven industry does not invest in products for markets that cannot pay,” she said, according to The New York Times. “WHO has been trying to mak...

Infants to get free treatment till age one in Rajasthan

Extending the scope of the Janani Shishu Suraksha Yojana (JSSY) with an aim to bring down the infant mortality rate (IMR) in the State, the Rajasthan government has decided...

In race for Ebola vaccines, technical hurdles loom large

Drugmakers sprinting to develop Ebola vaccines face a series of technical hurdles if they are to get millions of doses ready for use next year — even assuming clinica...